Bioresorbable polymers are groundbreaking technological materials that the body and don't can break down and require mechanical removals, such as sutures or the chlorhexidine chip. According to BlueQuark Research and Consulting, the global Bioresorbable Polymers market is expected to grow considerably during the forecasted period. Factors such as the increasing demand for surgical interventions are expected to drive the need for the Bioresorbable polymer market in the forecasted period. Further, the high demand for these polymers, as they can be easily dissolved in the body fluids without causing any residual side effects, and the rise in demand in drug delivery applications are expected to drive the need for the Bioresorbable polymers market in the forecasted period. Furthermore, favourable government regulations, the surge in investments, and a growing number of orthopaedic patients are expected to drive the need for the Bioresorbable polymer market in the forecasted period. However, the higher cost of bioresorbable polymers than that of conventional polymers and the need for quality control measures in developing countries are expected to obstruct the bioresorbable polymer market in the forecasted period.

Bioresorbable polymer-based implants are being extensively used for fracture fixation in orthopaedic surgery.

The surge in demand for the product for various healthcare applications is escalating the growth of the bioresorbable polymers market. Bioresorbable materials have applications in various medical indications, such as sutures, coronary & peripheral vascular scaffolds, tissue fixation screws, bone pins & anchors, drug delivery coatings, microspheres, and surgical meshes & matrices. The materials in this category include polymers, metals, ceramics, glasses, and materials of biological origins, such as natural collagen, which may allow for drug elution and delivery and perform a mechanical function. Bioresorbable polymers, such as polysaccharides, Polylactic Acid (PLA), polyglycolic acid, proteins, and polycaprolactone, are usually produced from vegetable oils obtained from rapeseed, or sunflower corn fibre, soybean, castor, heat by-products, food processing waste, corn, stems, paper mill sludge, livestock waste, potato, leaves, and others. The bio-based material in polymer varies depending on the type of feedstock that is utilized during manufacturing. The improved healthcare industry in the U.S. has resulted in a grown life expectancy and a surge in the geriatric population in the country. The synovial fluid within the orthopaedic joints usually drys due to ageing, which has driven the demand for elective orthopaedic surgeries, thus creating a positive growth opportunity for the industry. Polylactic acid exhibits biocompatibility, stiffness, and relatively high strength and modulus, making it suitable for manufacturing fixation devices, such as arrows, pins, washers, and screws in orthopaedic surgeries. PLA-based product has the benefits of getting naturally transformed into lactic acid in the body at fewer concentrations and can be safely removed by the body's excretory system. Also, its degradable nature allows it to safely degrade and dissolve, thus eliminating secondary surgery requiring component removal. With the huge supply of PLA across the U.S., the market finds usage across various biomedical applications in the country's healthcare sector.

North America dominated the global Bioresorbable polymers industry and accounted for the largest revenue share. This is attributed to the surging product consumption in the region's drug delivery and orthopaedics applications. The U.S. is the primary hub for research & development in the healthcare industry, further propelling the bioresorbable polymers sector in North America. Moreover, the increasing demand for orthopaedics and drug delivery applications supports this region's bioresorbable polymer demand. The global bioresorbable market is expected to register substantial growth in the future, attributed to rising demand from major applications such as orthopaedics and drug delivery. Other factors that drive the bioresorbable market are patient-friendliness, growing demand for drugs & medicines, increasing surgeries, and rising awareness among people. Orthopaedics emerged as the dominant application segment due to its various products, such as sutures, stents, screws, and pins used in different medical procedures. The wide product usage in biomedical settings, including prostheses and repairing injured joints, boosts segment growth. Resorbable polymer-based implants improve patient care and clinical results while decreasing the expense of further procedures and surgeries. The drug delivery application is expected to observe the fastest global market growth in the forecasted period.

Some market players are Corbion, Poly-Med, Foster Corporation, Evonik Industries AG ., and Sigma-Aldrich.

In February 2022, 3D Batek Introduced a new 3D InsertTM FCL scaffolds for large-scale 3D cell expansion. Unlike traditional 2D culture, 3D InsertTM PCL technology more closely resembled an in vivo. In September 2020, DSM announced a partnership with PBC Biomed, an Ireland-based medical device design and development company. This partnership initially focuses on developing regenerative bone adhesives for sale and cost-effective surgical procedures.

In May 2022, UBQ Materials, an Israel-based company, partnered with Polymer Metallization Specialist Polymertal to create lightweight, sustainable material for complex assemblies with metallic functionalities.

In September 2022, Ashland Group announced the plan to expand its Vital bioresorbable polymer producing and R&D site at the National Science Park. This is home to a network of ingenious organizations in Mullingar, Ireland, showcasing commitment to innovation in long-acting injectables. The capital expansion program started in June 2022 and is predicted to be completed in 2024.

The global Bioresorbable polymers Market report provides deep insight into the Industrial market's current and future state across various regions. The study comprehensively analyses the Bioresorbable polymers Market by segmenting based on By Product ( Polylactic acid (PLA), Polyglycolic acid (PGA), Polylactic-Co- Glycolic Acid (PLGA), Polycaprolactone (PCL), Others), Application (Drug Delivery, Orthopedic Devices, Others). The report examines the market drivers and restraints and the impact of Covid-19 on market growth in detail. The study covers emerging market size, trends, development, opportunities, and challenges in the industry. This report also covers extensively researched competitive landscape sections with prominent companies and profiles, including their market shares and projects.